Quality assurance standards for 503A compounding pharmacies include rigorous testing, sterility verification, and potency analysis to ensure medication safety and efficacy
Use appropriate personal protective equipment (PPE) at all times, including gloves and eye protection
The VA's trial adds to a growing body of ongoing research into GLP-1 medications' effects well beyond their original diabetes and weight-loss indications, as the drugs have continued attracting significant scientific and public interest since their initial approval and rapid rise in popularity in recent years
10.2147/DMSO.S348025 Summary Keywords semaglutide, subcutaneous, oral, adverse events, FDA Citation Niu K, Fan M, Gao W, Chen C and Dai G (2024) Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
Safety Considerations and Provider Guidance for GLP-1 Selection All GLP-1 drug names carry similar safety profiles: nausea, vomiting, and gastrointestinal disturbances are common early side effects